Quick Answer
CARLSMED, INC. reported Stockholders Equity of $98.87 million for fiscal year 2025.
CARLSMED, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $98.87M | +240.0% |
| 2024 | -$70.63M | -53.1% |
| 2023 | -$46.13M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $106.66M | +261.5% | +228.4% |
| June 30, 2025 | -$83.07M | -43.9% | -8.4% |
| March 31, 2025 | -$76.61M | -48.7% | -8.5% |
| December 31, 2024 | -$70.63M | -53.1% | -7.0% |
| September 30, 2024 | -$66.03M | — | -14.4% |
| June 30, 2024 | -$57.74M | — | -12.1% |
| March 31, 2024 | -$51.52M | — | -11.7% |
| December 31, 2023 | -$46.13M | — | — |
- CARLSMED, INC. showed an increase of +240.0% in Stockholders Equity compared to the prior fiscal year.
- Over the 2023–2025 period, CARLSMED, INC.’s stockholders equity has grown by 314.3% (from -$46.13 million to $98.87 million).
- The most recent figure is from CARLSMED, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: